This Week on NeurologyLive — February 15, 2021

Every week, the NeurologyLive staff prepares this preview of what to expect from our coverage. This week on NeurologyLive, there are a number of hot topics that we will be posting throughout the week. As always, our weekly coverage extends beyond just these topics, so make sure to check out the rest of the site!

We're running our first NeurologyLive audience survey of 2021, something we plan to conduct on a regular basis, so let your voice be heard! The insights derived from this short questionnaire will help our editorial team ensure that you get access to the insight, coverage, and content that is most meaningful to you. We kindly ask you to share 5 minutes of your time with us, in order to help us better craft our content to meet your needs and interests.

To take the survey, click here.

The latest in our NeuroVoices series, dedicated to conversations with leaders in the neurology community, will go live this Wednesday, February 17. This time, it features Marwan Sabbagh, MD, director of the Lou Ruvo Center for Brain Health at Cleveland Clinic, who discussed a newly initiated study that he will lead that examines the FDA-approved cancer drug lenalidomide in patients with Alzheimer disease. He provided background on how it came about, the use of repurposed drugs within the disease space, and what might be next if successful.

To check out the prior NeuroVoices conversations, click here.

A conversation with Bhooma Aravamuthan, MD, DPhil, assistant professor of pediatric neurology in the Department of Neurology at the Washington of University in St. Louis discussed, will air during NeurologyLive's segment on the Medical World News channel this Thursday, February 18, 2021. She spoke to the recently published results of a survey she and colleagues conducted into the role that child neurologists and neurodevelopmentalists play in diagnosing cerebral palsy.

To check out what's on the Medical World News channel now, click here.

Also this week, the latest in our News Network series, "Treating Epilepsy: Key Takeaways From AES 2020," has aired, featuring Amit Verma, MD, who examined the use of diazepam nasal spray in patients with epilepsy receiving concomitant maintenance benzodiazepines as presented in an interim analysis from a phase 3, long-term, open-label study.

To check out the whole series, click here.

Don't forget that all of the NeurologyLive Cure Connections series, "The Multiple Sclerosis Patient Journey," has been made available. This group conversation is led by June Halper, MSN, MSCN, who is joined by Patricia K. Coyle, MD, and Frederick Foley, PhD, as well as patient and care partner Ann Moore and Kathy Zelles. They discuss the specifics of patients' journies with MS and offer their perspectives on various facets of the disease.

To catch up on the rest of the series, click here.

In case you missed it: Our coverage of the American Epilepsy Society (AES) Annual Meeting is still ongoing here on NeurologyLive! A number of expert interviews are still being conducted, including with conference chair Barbara Jobst, MD, to learn and speak more about the data presented at the conference, as well as how the latest updates from the virtual conference floor are expected to impact clinical practice.

To catch up on post-AES 2020 coverage and expert perspectives, click here.